Valsartan and candesartan can inhibit deteriorating effects of angiotensin II on coronary endothelial function
The angiotensin II (Ang II) AT 1 -receptor antagonists, valsartan and candesartan, were compared with regard to their effect on Ang II-mediated changes in parameters of coronary endothelial function. Ang II (10 µM) induced increased concentrations of the vasoconstrictor endothelin, the procoagulator...
Main Authors: | Harald Seeger, Caroline Lippert, Diethelm Wallwiener, Alfred O Mueck |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi - SAGE Publishing
2001-06-01
|
Series: | Journal of the Renin-Angiotensin-Aldosterone System |
Online Access: | https://doi.org/10.3317/jraas.2001.016 |
Similar Items
-
Losartan inhibits in vitro platelet activation: comparison with candesartan and valsartan
by: Antonio Núñez, et al.
Published: (2000-06-01) -
Use of compounded dispersing media for extemporaneous pediatric syrups with candesartan cilexetil and valsartan
by: Musko Monika, et al.
Published: (2014-12-01) -
Internalization of Constitutively Active N111G Mutant of AT1 Receptor Induced by Angiotensin II–Receptor Antagonists Candesartan, Losartan, and Telmisartan: Comparison With Valsartan
by: Mohiuddin Ahmed Bhuiyan, et al.
Published: (2010-01-01) -
Cerebroprotective effects of angiotensin II receptor blockers: candesartan focus
by: O. D. Ostroumova, et al.
Published: (2018-09-01) -
Differential clinical profile of candesartan compared to other angiotensin receptor blockers
by: Zimlichman R
Published: (2011-12-01)